Radioligand binding assay methods are preferred to study the binding properties of test compounds in drug discovery, such GPCRs and ion channels. However, the regulatory requirements, high construction and maintenance costs prohibit most of labs from utilizing an exclusive radioisotope-based assay platform.
To address the problem, GenScript has constructed a powerful radioisotope-based assay platform as a low cost solution for your project. Based on the platform, scintillation proximity assay (SPA) and filtration binding assay are available tailored to your specifications. In addition, GenScript has validated many GPCR binding assays and hERG binding assay for your immediate screening.
|Cat. No.||Service|| |
Custom Receptor Binding Assay Services
Related Services and Products
- Non-radioactive GPCR Assay Services
- Non-radioactive Kinase Assay Services
- Membrane Preparations and Services
- Peptide Products
- Please contact us mentioning "Discovery Biology", our customer service representatives are available 24 hours a day, Monday through Friday to assist you with Form preparation.